Skin disorders, treatment

Sodium hydrosuifite saive, skin disorder treatment Mimosa tenuifiora leaf extract salves, burns Sambucus nigra oil salves, rashes Sambucus nigra oii saives, skin aiiments Sambucus nigra oil samarium sait mfg. 

Glycolic acid skin disease treatment Kukui (Aleurites moluccana) nut oil skin disorder treatment, infective Lactic acid... 

P-Carotene is prescribed in the treatment of the inherited skin disorder erythropoietic protoporphyria (EPP) to reduce the severity of photosensitivity reactions in such patients. The essential theoretical background relevant to the role of carotenoids as photoconductors has been reviewed (211). P-Carotene has also been used as a photoconductor in recording-media film. 

Oral treatment offers the advantage of bringing all the lesions at all sites under control, in addition to the absence of unpleasant cosmetic effects. In certain cases, it may be preferable to use oral treatment for C. albicans vaginitis and for extensive and persistent pityriasis versicolor, a skin disorder caused by Pityrosporum orbiculare. In the case of onychomycosis, a combination treatment, topical plus systemic, is required. It is preferable to use oral treatment for deep and systemic mycoses, though intravenous or intrathecal treatment is sometimes required. 

Bismuth subgaHate [12552-60-2] (basic bismuth gaHate), Dermatol, is a bright yellow powder that can be prepared by the interaction of bismuth nitrate and gaUic acid in an acetic acid medium. It has been employed as a dusting powder in some skin disorders and as an ingredient of suppositories for the treatment of hemorrhoids (183,185). It has been taken orally for many years by colostomy patients in order to control fecal odors, but the dmg may cause serious neurological problems (186). 

Topical Drugs Used in the Treatment of Skin Disorders... 

List the types of drugs used in the treatment of skin disorders. 

Discuss the general drug actions, uses, and reactions of and any contraindications, precautions, and interactions associated with drugs used in the treatment of skin disorders. 

List the goals of treatment for patients with common skin disorders. 

Identify adverse effects that may result from pharmacologic agents used in the treatment of common skin disorders. 

Create educational information for patients about common skin disorders, including appropriate self-management, available drug treatment options, and anticipated therapeutic responses. 

General treatment goals for patients with skin disorders are to relieve bothersome symptoms, remove precipitating factors, prevent recurrences, avoid adverse treatment effects, and improve quality of life. 

A potentially interesting application of (acyloxy)methyl ester prodrugs can be found in delivery through skin of antibacterial agents. Nalidixic acid (8.53, R = H), a topoisomerase II inhibitor, showed promising activity in the treatment of antiproliferative skin disorders, notably psoriasis. To improve the... 

Erdogan, M., Wright, J. R., Jr. and McAlister, V. C., Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders experimental studies in a murine model. Br. J. Dermatol., 146, 964—67, 2002. 

Dermatoiogic changes Patients have rarely developed exfoliative skin disorders during treatment with fluconazole. 

Phototherapy is the generic term covering therapies which use light either with or without a sensitiser. Those that do not require a sensitiser use the natural chromophores within the tissue to perform this function e.g. treatment of vitamin D deficiency in rickets, and neonatal jaundice). Those that do use an added sensitiser include photochemotherapy (largely psoriasis and skin disorders) and photodynamic therapy (currently mainly cancer). Photodynamic therapy is differentiated from photochemotherapy by its additional requirement for the presence of oxygen at molecular or ambient levels.In this text we will deal only with photodynamic therapy since, at the present time, this is the main driving force in phototherapy. ° ... 

Work during the last ten years on photodynamic therapy (PDT) has established the methodology as effective in the early treatment of cancers, and in the treattnent of certain skin disorders and viral infections. Approval by the regulatory authorities for sensitisers in this process began in 1993 when Canada allowed the use of Photofrin (QLT Therapeutics), an action followed later by most countries around the world. Now many other companies have sensitisers at late stage clinical dials (2001), see below in Table 4.5. An excellent introduction to the chemistry of this topic is provided in the book written by Bonnett. ... 

For the treatment of various skin disorders, local application of drugs in the form of cream, ointment, gel etc., appears to be the ideal and convenient form of management. However, in severe conditions different drugs can also be given by oral routes. The different agents used in various skin disorders are classified as in table 13.2.1. 

Indications Treatment of patients with hairy-cell leukemia, malignant melanoma, follicular non-Hodgkin s lymphoma (NHL), AIDS-related Kaposi s sarcoma, chronic hepatitis C, and the skin disorder, condylomata acuminata... 

---